Akamis Bio Company Profile, Contacts & Intelligence

Akamis Bio Overview

Headquartered in Cambridge, Massachusetts, Akamis Bio is a clinical-stage oncology company developing systemically administered immunotherapies to treat solid tumors, initially in patients with locally advanced rectal cancer (LARC). Its proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform is designed to deliver novel immunotherapeutic proteins, biomolecules and transgene combinations to treat solid tumors, with its lead clinical-stage program, NG-350A, driving intratumoral expression of a CD40 agonist monoclonal antibody. To learn more, please visit www.akamisbio.com.

Headquarters

Abingdon, Oxfordshire, United Kingdom

Website

+www.akamisbio.com

Industry

Biotechnology Research

Founded

2010

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Akamis Bio Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Akamis Bio People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Akamis Bio Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to Akamis Bio

Explore companies in related markets and compare their industry and employee estimates.